The Clinical Implementation Core (CIC) is the MDRTC name for the model demonstration unit, a required core in DRTCs. The CIC addresses issues in the first phase of the translation sequence, namely selection and adaptation of research findings for clinical care and the development and demonstration of model care programs. The principal model care development efforts of the CIC will occur in the context of the two projects for which this core will be responsible. These are D&E Project #1 -- Elderly Project, and D&E Project #2 -- Neuropathy Project. The conduct of these two projects will be CIC Aims #1 and #2, respectively.
The third Aim of the CIC will be to facilitate clinical research in diabetes. Two special activities will be included here: 1) the screening and clinical evaluation of patients who are candidates for experimental gene therapy maneuvers, and 2) recruitment of diabetic members and members of an unknown diabetic status of another large four-generation branch of the MODY RW pedigree to expand the registry of family members available for study of molecular genetic, hormonal and metabolic aspects of MODY.
The fourth Aim of the CIC addresses development of professional and patient education programs in diabetes and the demonstration of model diabetes care to health professional students. The staff of the CIC will be health professionals with special qualifications in diabetes who provide clinical expertise to the Biomedical Research and the D&E Division, its projects and cores.

Project Start
2000-12-01
Project End
2001-11-30
Budget Start
Budget End
Support Year
24
Fiscal Year
2001
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Kumar, Navasuja; Pop-Busui, Rodica; Musch, David C et al. (2018) Central Corneal Thickness Increase Due to Stromal Thickening With Diabetic Peripheral Neuropathy Severity. Cornea 37:1138-1142
Wilson, Matthew J; Sen, Ananda; Bridges, Dave et al. (2018) Higher baseline expression of the PTGS2 gene and greater decreases in total colonic fatty acid content predict greater decreases in colonic prostaglandin-E2 concentrations after dietary supplementation with ?-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 139:14-19
Sucularli, Ceren; Thomas, Peedikayil; Kocak, Hande et al. (2018) High-throughput gene expression analysis identifies p53-dependent and -independent pathways contributing to the adrenocortical dysplasia (acd) phenotype. Gene 679:219-231
Kady, Nermin M; Liu, Xuwen; Lydic, Todd A et al. (2018) ELOVL4-Mediated Production of Very Long-Chain Ceramides Stabilizes Tight Junctions and Prevents Diabetes-Induced Retinal Vascular Permeability. Diabetes 67:769-781
Malik, Ahmed M; Miguez, Roberto A; Li, Xingli et al. (2018) Matrin 3-dependent neurotoxicity is modified by nucleic acid binding and nucleocytoplasmic localization. Elife 7:
Lee, Pearl G; Ha, Jinkyung; Blaum, Caroline S et al. (2018) Patterns of physical activity in sedentary older individuals with type 2 diabetes. Clin Diabetes Endocrinol 4:7
Ramos, Carla J; Lin, Chengmao; Liu, Xuwen et al. (2018) The EPAC-Rap1 pathway prevents and reverses cytokine-induced retinal vascular permeability. J Biol Chem 293:717-730
Djuric, Zora; Bassis, Christine M; Plegue, Melissa A et al. (2018) Colonic Mucosal Bacteria Are Associated with Inter-Individual Variability in Serum Carotenoid Concentrations. J Acad Nutr Diet 118:606-616.e3
Vollbrecht, Peter J; Nesbitt, Kathryn M; Mabrouk, Omar S et al. (2018) Cocaine and desipramine elicit distinct striatal noradrenergic and behavioral responses in selectively bred obesity-resistant and obesity-prone rats. Behav Brain Res 346:137-143
Jiang, Lin; Su, Haoran; Keogh, Julia M et al. (2018) Neural deletion of Sh2b1 results in brain growth retardation and reactive aggression. FASEB J 32:1830-1840

Showing the most recent 10 out of 1081 publications